If approved, this would be the first FDA approval for a weight loss drug since 1999. Although the FDA does not have to follow the committee’s recommendation, it usually does. The drug was rejected in 2010 per concerns about side effects such as possible heart problems and birth defects.
More Articles on Gastroenterology:
Starting From Scratch: Top 5 Tips on ASC Development From Manhattan Endoscopy Center
FDA Approves invendo medical’s Single-Use Colonoscope
Mayo Clinic Research Shows Virtual Colonoscopies Suitable for People Over 65
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.